 | |||||||
| lose weight | |||||||
| NEWS | |||||||
Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |